Malaria vaccine - Sinobiomed
Alternative Names: PfCP2.9Latest Information Update: 02 Oct 2021
At a glance
- Originator Sinobiomed
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria